Your browser doesn't support javascript.
Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia.
Lo Tartaro, Domenico; Neroni, Anita; Paolini, Annamaria; Borella, Rebecca; Mattioli, Marco; Fidanza, Lucia; Quong, Andrew; Petes, Carlene; Awong, Geneve; Douglas, Samuel; Lin, Dongxia; Nieto, Jordan; Gozzi, Licia; Franceschini, Erica; Busani, Stefano; Nasi, Milena; Mattioli, Anna Vittoria; Trenti, Tommaso; Meschiari, Marianna; Guaraldi, Giovanni; Girardis, Massimo; Mussini, Cristina; Gibellini, Lara; Cossarizza, Andrea; De Biasi, Sara.
  • Lo Tartaro D; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41125, Modena, Italy.
  • Neroni A; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41125, Modena, Italy.
  • Paolini A; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41125, Modena, Italy.
  • Borella R; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41125, Modena, Italy.
  • Mattioli M; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41125, Modena, Italy.
  • Fidanza L; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia School of Medicine, Via Campi 287, 41125, Modena, Italy.
  • Quong A; Fluidigm Corporation, 2 Tower Place, Suite 2000, South San Francisco, 94080, CA, USA.
  • Petes C; Fluidigm Corporation, 2 Tower Place, Suite 2000, South San Francisco, 94080, CA, USA.
  • Awong G; Fluidigm Corporation, 2 Tower Place, Suite 2000, South San Francisco, 94080, CA, USA.
  • Douglas S; Fluidigm Corporation, 2 Tower Place, Suite 2000, South San Francisco, 94080, CA, USA.
  • Lin D; Fluidigm Corporation, 2 Tower Place, Suite 2000, South San Francisco, 94080, CA, USA.
  • Nieto J; Fluidigm Corporation, 2 Tower Place, Suite 2000, South San Francisco, 94080, CA, USA.
  • Gozzi L; Infectious Diseases Clinics, AOU Policlinico di Modena, via del Pozzo 71, 41124, Modena, Italy.
  • Franceschini E; Infectious Diseases Clinics, AOU Policlinico di Modena, via del Pozzo 71, 41124, Modena, Italy.
  • Busani S; Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.
  • Nasi M; Department of Anesthesia and Intensive Care, AOU Policlinico and University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.
  • Mattioli AV; Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.
  • Trenti T; Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.
  • Meschiari M; National Institute for Cardiovascular Research, via Irnerio 48, 40126, Bologna, Italy.
  • Guaraldi G; Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, AUSL/AOU Policlinico, 41124, Modena, Italy.
  • Girardis M; Infectious Diseases Clinics, AOU Policlinico di Modena, via del Pozzo 71, 41124, Modena, Italy.
  • Mussini C; Infectious Diseases Clinics, AOU Policlinico di Modena, via del Pozzo 71, 41124, Modena, Italy.
  • Gibellini L; Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.
  • Cossarizza A; Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.
  • De Biasi S; Department of Anesthesia and Intensive Care, AOU Policlinico and University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.
Commun Biol ; 5(1): 590, 2022 06 16.
Article in English | MEDLINE | ID: covidwho-1960513
ABSTRACT
Aging is a major risk factor for developing severe COVID-19, but few detailed data are available concerning immunological changes after infection in aged individuals. Here we describe main immune characteristics in 31 patients with severe SARS-CoV-2 infection who were >70 years old, compared to 33 subjects <60 years of age. Differences in plasma levels of 62 cytokines, landscape of peripheral blood mononuclear cells, T cell repertoire, transcriptome of central memory CD4+ T cells, specific antibodies are reported along with features of lung macrophages. Elderly subjects have higher levels of pro-inflammatory cytokines, more circulating plasmablasts, reduced plasmatic level of anti-S and anti-RBD IgG3 antibodies, lower proportions of central memory CD4+ T cells, more immature monocytes and CD56+ pro-inflammatory monocytes, lower percentages of circulating follicular helper T cells (cTfh), antigen-specific cTfh cells with a less activated transcriptomic profile, lung resident activated macrophages that promote collagen deposition and fibrosis. Our study underlines the importance of inflammation in the response to SARS-CoV-2 and suggests that inflammaging, coupled with the inability to mount a proper anti-viral response, could exacerbate disease severity and the worst clinical outcome in old patients.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Aged / Humans Language: English Journal: Commun Biol Year: 2022 Document Type: Article Affiliation country: S42003-022-03537-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Aged / Humans Language: English Journal: Commun Biol Year: 2022 Document Type: Article Affiliation country: S42003-022-03537-z